A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2012
At a glance
- Drugs Sepantronium bromide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 06 Jun 2012 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 04 Aug 2006 Status change
- 19 Jan 2006 New trial record.